The data analytics firm's quarterly results soared past estimates, fueled by surging government contracts. CEO Alex Karp touts 'iconic' performance while facing renewed scrutiny over the company's role in immigration enforcement.
CEO Sam Altman announces a strategic hiring slowdown as OpenAI navigates profitability challenges and shifts toward using AI to build AI, raising questions about data quality and industry stability.
A male tourist in his 60s was killed in a violent encounter with a wild bull elephant, marking the third confirmed fatality linked to the same animal. Park authorities are now weighing intervention options as human-wildlife conflict escalates.
The Walt Disney Company announced blockbuster quarterly earnings driven by historic box office and streaming performance, though profits were pressured by a resolved YouTube dispute, rising costs, and a broader slowdown in international travel to U.S. destinations.
Jumia Technologies' shares have skyrocketed over 244% in the past year, a stunning rally that appears disconnected from its recent financial performance. This surge highlights the complex dynamics of growth investing in emerging markets.
Financial disclosures show the growing religious instruction nonprofit LifeWise Academy increased its fundraising haul last year while its net profit fell, as it expands its reach into public schools across Ohio and nationwide.
Despite reporting revenue and earnings that topped Wall Street forecasts, Triumph Financial's stock fell post-earnings. While management pointed to strength in its payments network and cost controls, analysts on the call focused on persistent challenges in the freight sector and the sustainability of margins.
Chemical and ammunition manufacturer Olin Corporation reported fourth-quarter results that missed internal forecasts, pressured by plant disruptions, supply issues, and a sharp year-end drop in chlorine demand. Executives emphasized cash preservation and cost control while navigating what they term an extended market downturn.
Shares of the alternative asset manager have retreated sharply from recent highs, prompting investors to question whether the stock's premium valuation remains justified. We examine the key metrics and what the pullback might signal.
Stryker Corporation's latest earnings report, driven by its MedSurg, Neurotechnology divisions and the Mako surgical robot, has reignited investor debate. With shares near $370 and a bullish fair value estimate of $427, analysts are weighing robust growth against a premium valuation.
First Citizens BancShares delivered Q4 revenue and adjusted EPS above analyst forecasts, yet its stock fell. While management pointed to strong fundamentals, analysts probed pressures on margins, tech spending, and integration challenges.
New analysis from NRC Health reveals that integrating real-time patient sentiment tools like Net Promoter Score with traditional HCAHPS surveys can accelerate improvements in care quality and directly impact Medicare reimbursements under value-based programs.
Citizens reiterates a 'Market Outperform' rating and $396 price target for BeOne Medicines (ONC), driven by robust Phase 3 trial results in gastric cancer. The firm highlights the company's strong pipeline and cash position as key growth drivers.
KLA Corporation reports robust fiscal 2025 results driven by AI demand, but warns of supply constraints and geopolitical factors tempering near-term growth, with a significant acceleration projected for late 2026 and 2027.
All eyes are on AbbVie as it prepares to release its fourth-quarter earnings. With a history of topping revenue forecasts, the market watches to see if its strategic shifts can continue to deliver amid evolving industry pressures.
Industrial battery giant EnerSys (ENS) is set to report its fiscal fourth-quarter results after Wednesday's market close. Investors are weighing strong recent performance against a history of revenue misses and a tempered growth outlook.
As Steris prepares to report its fiscal fourth-quarter results, investors are watching to see if the company can maintain its recent streak of topping revenue estimates against a backdrop of mixed signals from the broader healthcare equipment sector.
The global electronics manufacturer is poised to release its quarterly results Wednesday, with investors watching for signs of stabilization after a period of revenue contraction.
Silgan Holdings is set to report fourth-quarter earnings Wednesday morning, with Wall Street eyeing slowing revenue growth and the company's ability to outperform in a mixed industrial packaging landscape.
As Equitable Holdings prepares to report fourth-quarter results, investors are watching for signs of stability amid a turbulent period for insurance stocks. With revenue growth expected to stall, the focus shifts to profitability and guidance.
